EMMA ELLIS: Open Payments
NPI 1548836158 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,913 in 139 payments from 17 companies in 2025. Trend: 2023 $2,647 · 2024 $2,935 · 2025 $2,913
Food & beverage: $2,813Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 24 | $573 |
| Janssen Biotech, Inc. | 16 | $478 |
| ABBVIE INC. | 29 | $364 |
| PFIZER INC. | 7 | $201 |
| UCB, Inc. | 13 | $198 |
| Amgen Inc. | 8 | $195 |
| Regeneron Healthcare Solutions, Inc. | 8 | $188 |
| Galderma Laboratories, L.P. | 10 | $149 |
| Lilly USA, LLC | 6 | $145 |
| Novartis Pharmaceuticals Corporation | 4 | $97 |
Products named: OPZELURA, TREMFYA, SKYRIZI, DUPIXENT, CIBINQO, Bimzelx, OTEZLA, NEMLUVIO.
Industry payments across VA — which companies pay providers there.
